Why the study?
What is the prevalence of primary aldosteronism indicators in patients with resistant hypertension?
What is the prevalence of primary aldosteronism indicators in patients with resistant hypertension?
In Brazilian patients with resistant hypertension, the prevalence of an elevated aldosterone-to-renin ratio was 15.7%, but actual aldosterone-producing adenomas were rare.
Answers are grounded in this paper and cite their sources.
Highlights substantial ARR elevation in resistant hypertension; leaves open confirmatory testing and outcome impact in diverse cohorts.
The objective was to estimate the prevalence of plasma aldosterone concentration:plasma renin activity ratio >30 ng/dL:ng/mL/h in patients with resistant hypertension and to describe the computed tomography findings of adrenal glands in those with elevated ratios. In a cross-sectional design, 492 patients were enrolled. All patients with plasma aldosterone concentration:plasma renin activity ratio >or=30 ng/dL:ng/mL/h (n=77) underwent abdominal computed tomography. Patients with an adrenal image of possible aldosterone-producing adenoma underwent a saline-loading test. The prevalence of elevated plasma aldosterone concentration:plasma renin activity ratio was 15.7% (95% confidence interval, 12.6-19.2). Twelve patients showed adrenal abnormalities on computed tomography. The level of renin was low in 50% of the sample. Results indicate a low prevalence of aldosterone-producing adenoma. Our evidence points out the importance of confirming the hypothesis that essential hypertension, low-renin hypertension, and idiopathic hyperaldosteronism could be the same disease, but at different neurohormonal stages, and aldosterone-producing adenoma may be yet another disease.
No takes yet. Share an insight, caveat, or question.
Nogueira et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: